跳至主要内容
临床试验/DRKS00011790
DRKS00011790招募中未知

Identification of individual cancer mutations and analysis of their immunogenicity - RB_T002

BioNTech SE0 个研究点目标入组 1,000 人开始时间: 2017年4月6日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
BioNTech SE
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • signed informed consent; Health condition, that allows planned interventions (according clinical standards);
  • Hemoglobin value = 10,0 g / dl;
  • Patient with suspected/confirmed malign tumor with either already excised/planned excision of tumor material and/or possibility of tumor biopsies exclusively taken for the research project

排除标准

  • Known pregnancy or breastfeeding;
  • Known acute or chronically active hepatitis infection, known HIV infection;
  • Patients who are incapable to give consent or are not able to understand the nature of the project;
  • serious concomitant disease or other circumstances (e.g. psychological, familial, sociological or geographical circumstances), which do not allow an adequate participation

研究者

发起方
BioNTech SE

相似试验

Identification of individual cancer mutations and... | 临床试验